KTTA

Pasithea Therapeutics Corp. (KTTA)

About Pasithea Therapeutics Corp. (KTTA)

Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.

Details

Daily high

$2.78

Daily low

$2.58

Price at open

$2.67

52 Week High

$9.40

52 Week Low

$2.37

Market cap

3.3M

Dividend yield

0.00%

Volume

23,969

Avg. volume

21,466

P/E ratio

-.17

Pasithea Therapeutics Corp. News